National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Primary CNS Lymphoma Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 06/18/2008



General Information About Primary CNS Lymphoma






Staging Primary CNS Lymphoma






Recurrent Primary CNS Lymphoma






Treatment Option Overview






Treatment Options for Primary CNS Lymphoma






To Learn More About Primary CNS Lymphoma






Get More Information From NCI






Changes to This Summary (06/18/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Recurrent Primary CNS Lymphoma

Recurrent primary central nervous system (CNS) lymphoma is cancer that has recurred (come back) after it has been treated. Primary CNS lymphoma commonly recurs in the brain or the eye.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov